Incidence and risk factors for methotrexate-induced pulmonary disease during treatment of rheumatoid arthritis.

被引:0
|
作者
Cannon, GW
Cerveny, KC
Finck, BK
Simpson, KM
Strand, V
机构
[1] VA & Univ Utah, Salt Lake City, UT USA
[2] Immunex Corp, Seattle, WA USA
[3] Aventis, Bridgewater, NJ USA
[4] Stanford Univ, Palo Alto, CA 94304 USA
来源
ARTHRITIS AND RHEUMATISM | 2002年 / 46卷 / 09期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S166 / S166
页数:1
相关论文
共 50 条
  • [1] Methotrexate-induced pulmonary disease during treatment of rheumatoid arthritis in large clinical trials.
    Cannon, GW
    Finck, BK
    Simspon, KM
    Strand, V
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S341 - S341
  • [2] Reversal of methotrexate-induced hair loss with leucovorin calcium in rheumatoid arthritis.
    Bobrove, AM
    ARTHRITIS AND RHEUMATISM, 1996, 39 (06): : R5 - R5
  • [3] The incidence of cardiovascular risk factors in rheumatoid arthritis.
    Gonalez, A
    Maradit-Kremers, H
    Crowson, C
    Gabriel, S
    JOURNAL OF INVESTIGATIVE MEDICINE, 2005, 53 (02) : S390 - S390
  • [4] Methotrexate-induced hepatotoxicity in rheumatoid arthritis
    Sotoudehmanesh, Rasoul
    Anvari, Bita
    Akhlaghi, Masoumeh
    Shahraeeni, Shadi
    Khatibian, Morteza
    Mikaeli, Javad
    Ansari, Reza
    Asle-Soleimani, Hossein
    GASTROENTEROLOGY, 2008, 134 (04) : A412 - A412
  • [5] Methotrexate-induced pneumonitis in rheumatoid arthritis
    Moyano, MS
    Olmo, EP
    Soler, L
    Siles, JC
    Fernández, FA
    REVISTA CLINICA ESPANOLA, 2002, 202 (10): : 569 - 570
  • [6] Risk factors for methotrexate-induced abnormal laboratory monitoring results in patients with rheumatoid arthritis
    Kent, PD
    Luthra, HS
    Michet, CJ
    JOURNAL OF RHEUMATOLOGY, 2004, 31 (09) : 1727 - 1731
  • [7] Methotrexate-Induced AKI: Incidence, Risk Factors, and Recovery
    Gupta, Mohit
    Lin, I-Hsin
    Latcha, Sheron
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 577 - 577
  • [8] Methotrexate-induced dysautonomia in a patient with rheumatoid arthritis
    Laudisio, Alice
    Margiotta, Domenico P. E.
    Zuccala, Giuseppe
    Afeltra, Antonella
    Incalzi, Raffaele Antonelli
    RHEUMATOLOGY, 2017, 56 (08) : 1428 - 1430
  • [9] Ondansetron therapy prevents from refractory and severe methotrexate-induced nausea in rheumatoid arthritis.
    Blanco, R
    GonzalezGay, MA
    GarciaPorrua, C
    GarciaPais, MJ
    Ibanez, D
    SanchezAndrade, A
    VazquezCaruncho, M
    ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 971 - 971
  • [10] Methotrexate-induced panniculitis in a patient with rheumatoid arthritis
    Al Maashari, Raghda
    Hamodat, Mowafak M.
    ACTA DERMATOVENEROLOGICA ALPINA PANNONICA ET ADRIATICA, 2016, 25 (04): : 79 - 81